This financial flexibility positions Cipher to pursue additional acquisitions while maintaining a leverage ratio below 1.5x earnings. The company’s liquidity position is detailed in this slide: Cipher ...
The specialty pharmaceutical company reported Q1 2025 earnings that fell short of analyst expectations, with EPS of $0.10 missing the forecasted $0.14, despite a substantial 105% year-over-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results